| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, IgE | 113 | 2021 | 374 | 7.170 |
Why?
|
| Immunoglobulin E | 66 | 2021 | 1480 | 2.480 |
Why?
|
| Calcium Channels | 14 | 2024 | 622 | 2.180 |
Why?
|
| Receptors, Fc | 42 | 2000 | 537 | 2.110 |
Why?
|
| Mast Cells | 39 | 2021 | 1404 | 1.890 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 25 | 1992 | 317 | 1.590 |
Why?
|
| Calcium Signaling | 11 | 2024 | 734 | 1.370 |
Why?
|
| Hypersensitivity | 15 | 2021 | 1168 | 1.220 |
Why?
|
| Calcium | 29 | 2024 | 5770 | 1.080 |
Why?
|
| Receptors, IgG | 21 | 2005 | 559 | 1.000 |
Why?
|
| Protein-Tyrosine Kinases | 28 | 2004 | 2425 | 0.960 |
Why?
|
| Cell Degranulation | 9 | 2013 | 276 | 0.910 |
Why?
|
| Enzyme Precursors | 13 | 2004 | 165 | 0.780 |
Why?
|
| Signal Transduction | 42 | 2014 | 23605 | 0.710 |
Why?
|
| Calcium Channels, T-Type | 2 | 2019 | 28 | 0.690 |
Why?
|
| src-Family Kinases | 13 | 2004 | 539 | 0.580 |
Why?
|
| Basophils | 21 | 2014 | 392 | 0.540 |
Why?
|
| Cell Membrane | 14 | 2019 | 3635 | 0.510 |
Why?
|
| TRPC Cation Channels | 6 | 2024 | 108 | 0.500 |
Why?
|
| Phosphatidylinositol Phosphates | 4 | 2001 | 201 | 0.500 |
Why?
|
| Antigens, Differentiation | 11 | 1996 | 920 | 0.480 |
Why?
|
| Anaphylaxis | 7 | 2013 | 738 | 0.480 |
Why?
|
| NFATC Transcription Factors | 1 | 2016 | 391 | 0.440 |
Why?
|
| Endoplasmic Reticulum | 5 | 2019 | 1132 | 0.430 |
Why?
|
| Hypersensitivity, Immediate | 7 | 2004 | 346 | 0.430 |
Why?
|
| Calcium Channels, L-Type | 4 | 2019 | 243 | 0.420 |
Why?
|
| Cell Line | 51 | 2017 | 15546 | 0.410 |
Why?
|
| Phosphoric Monoester Hydrolases | 7 | 2001 | 415 | 0.410 |
Why?
|
| TRPM Cation Channels | 8 | 2012 | 139 | 0.410 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 890 | 0.400 |
Why?
|
| Trichuris | 1 | 2012 | 32 | 0.400 |
Why?
|
| Nut Hypersensitivity | 1 | 2012 | 33 | 0.400 |
Why?
|
| Membrane Proteins | 13 | 2009 | 7850 | 0.400 |
Why?
|
| Protein Tyrosine Phosphatases | 8 | 2013 | 457 | 0.390 |
Why?
|
| Transfection | 21 | 2008 | 5739 | 0.380 |
Why?
|
| Phosphorylation | 31 | 2008 | 8292 | 0.380 |
Why?
|
| Ovum | 1 | 2012 | 187 | 0.380 |
Why?
|
| Animals | 129 | 2024 | 168800 | 0.370 |
Why?
|
| Th1 Cells | 1 | 2016 | 1041 | 0.360 |
Why?
|
| T-Lymphocytes | 9 | 2019 | 10260 | 0.360 |
Why?
|
| Cation Transport Proteins | 2 | 2004 | 325 | 0.360 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 820 | 0.350 |
Why?
|
| Molecular Sequence Data | 36 | 2006 | 17597 | 0.340 |
Why?
|
| Th17 Cells | 1 | 2016 | 787 | 0.330 |
Why?
|
| Urticaria | 4 | 1999 | 151 | 0.320 |
Why?
|
| Phosphoproteins | 9 | 2005 | 2445 | 0.320 |
Why?
|
| Antigens, CD | 8 | 2005 | 4025 | 0.320 |
Why?
|
| Immunoglobulin G | 15 | 2005 | 4556 | 0.320 |
Why?
|
| Receptors, Antigen, B-Cell | 8 | 2003 | 545 | 0.320 |
Why?
|
| Macromolecular Substances | 22 | 2003 | 1430 | 0.310 |
Why?
|
| Mice | 70 | 2024 | 81839 | 0.310 |
Why?
|
| Models, Immunological | 3 | 2007 | 517 | 0.300 |
Why?
|
| Amino Acid Sequence | 27 | 2006 | 13400 | 0.280 |
Why?
|
| Receptors, Immunologic | 14 | 1999 | 1416 | 0.280 |
Why?
|
| Rats | 41 | 2013 | 23717 | 0.270 |
Why?
|
| Neoplasm Proteins | 3 | 2009 | 3594 | 0.270 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2016 | 2570 | 0.270 |
Why?
|
| Intracellular Space | 1 | 2008 | 198 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2008 | 1962 | 0.270 |
Why?
|
| Phosphotyrosine | 6 | 2008 | 459 | 0.260 |
Why?
|
| Enzyme Activation | 16 | 2003 | 3584 | 0.260 |
Why?
|
| Tyrosine | 11 | 2005 | 1427 | 0.250 |
Why?
|
| Passive Cutaneous Anaphylaxis | 4 | 2005 | 31 | 0.250 |
Why?
|
| Cloning, Molecular | 18 | 2006 | 4163 | 0.250 |
Why?
|
| Immunosorbent Techniques | 7 | 1990 | 174 | 0.240 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1996 | 489 | 0.230 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2005 | 282 | 0.220 |
Why?
|
| Type C Phospholipases | 5 | 1999 | 284 | 0.220 |
Why?
|
| 3T3 Cells | 8 | 2001 | 1079 | 0.220 |
Why?
|
| Lymphocyte Activation | 4 | 2016 | 5503 | 0.220 |
Why?
|
| Receptor Aggregation | 5 | 1995 | 71 | 0.220 |
Why?
|
| Lymphocytes | 2 | 2009 | 2602 | 0.220 |
Why?
|
| Polymorphism, Genetic | 7 | 2008 | 4249 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2005 | 2898 | 0.200 |
Why?
|
| Immunoblotting | 7 | 2013 | 1644 | 0.200 |
Why?
|
| Staphylococcal Protein A | 4 | 1986 | 39 | 0.200 |
Why?
|
| U937 Cells | 5 | 2004 | 259 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2004 | 2879 | 0.190 |
Why?
|
| Cations | 1 | 2002 | 239 | 0.190 |
Why?
|
| Mice, Knockout | 13 | 2024 | 14456 | 0.190 |
Why?
|
| Autoantibodies | 6 | 2001 | 2114 | 0.180 |
Why?
|
| Jurkat Cells | 4 | 2006 | 738 | 0.180 |
Why?
|
| Ion Transport | 4 | 2006 | 322 | 0.180 |
Why?
|
| Up-Regulation | 5 | 2006 | 4133 | 0.180 |
Why?
|
| Isoenzymes | 5 | 2000 | 1688 | 0.180 |
Why?
|
| Base Sequence | 18 | 2002 | 12405 | 0.170 |
Why?
|
| Drosophila Proteins | 2 | 2007 | 1704 | 0.170 |
Why?
|
| B-Lymphocytes | 6 | 2001 | 4782 | 0.160 |
Why?
|
| Receptors, Purinergic P2X2 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Macrophages | 4 | 2012 | 5776 | 0.160 |
Why?
|
| Gene Amplification | 2 | 2001 | 1088 | 0.160 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2019 | 72 | 0.160 |
Why?
|
| Leukemia, Basophilic, Acute | 6 | 2003 | 15 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2008 | 3733 | 0.160 |
Why?
|
| Genes | 7 | 1992 | 1824 | 0.150 |
Why?
|
| Intracellular Fluid | 3 | 2006 | 201 | 0.150 |
Why?
|
| Membrane Potentials | 5 | 2006 | 1085 | 0.150 |
Why?
|
| Models, Molecular | 12 | 2006 | 5382 | 0.150 |
Why?
|
| Recombinant Proteins | 14 | 2006 | 6493 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2005 | 2196 | 0.150 |
Why?
|
| Receptors, Muscarinic | 2 | 1996 | 156 | 0.150 |
Why?
|
| Blood Proteins | 2 | 2001 | 1186 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2002 | 4521 | 0.150 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2019 | 130 | 0.150 |
Why?
|
| Allergens | 5 | 2021 | 1435 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 10 | 2003 | 6102 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2431 | 0.140 |
Why?
|
| Structure-Activity Relationship | 6 | 2008 | 3051 | 0.140 |
Why?
|
| Cytokines | 8 | 2016 | 7426 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 7 | 2008 | 3751 | 0.140 |
Why?
|
| Humans | 116 | 2021 | 766117 | 0.140 |
Why?
|
| Autoimmune Diseases | 3 | 2001 | 2249 | 0.140 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 1725 | 0.140 |
Why?
|
| Amino Acid Motifs | 4 | 2004 | 924 | 0.140 |
Why?
|
| Vaccines | 1 | 2005 | 840 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 924 | 0.130 |
Why?
|
| Protein Conformation | 11 | 2003 | 3946 | 0.130 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2001 | 245 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 2017 | 110 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2001 | 667 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2000 | 3436 | 0.130 |
Why?
|
| Molecular Weight | 8 | 2002 | 2161 | 0.130 |
Why?
|
| GTP-Binding Proteins | 3 | 1996 | 945 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2006 | 2927 | 0.130 |
Why?
|
| Kinetics | 11 | 2001 | 6273 | 0.120 |
Why?
|
| Restriction Mapping | 6 | 2001 | 848 | 0.120 |
Why?
|
| Antigen Presentation | 4 | 2009 | 1250 | 0.120 |
Why?
|
| Serotonin | 5 | 2005 | 1045 | 0.120 |
Why?
|
| Immunoglobulin Fc Fragments | 3 | 2001 | 287 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2003 | 433 | 0.120 |
Why?
|
| Gene Expression Regulation | 10 | 2014 | 11906 | 0.120 |
Why?
|
| Dendritic Cells | 5 | 2014 | 2747 | 0.120 |
Why?
|
| Receptors, Antigen | 1 | 1994 | 51 | 0.120 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 431 | 0.120 |
Why?
|
| Phospholipases A | 1 | 1995 | 204 | 0.120 |
Why?
|
| Protein Folding | 2 | 1996 | 868 | 0.120 |
Why?
|
| Egg Hypersensitivity | 1 | 2014 | 47 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 11 | 1998 | 6215 | 0.110 |
Why?
|
| Cells, Cultured | 13 | 2014 | 18967 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 827 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 1996 | 335 | 0.110 |
Why?
|
| Antigens | 5 | 1999 | 1437 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 1995 | 262 | 0.110 |
Why?
|
| src Homology Domains | 4 | 1999 | 361 | 0.110 |
Why?
|
| Receptors, KIR | 1 | 2013 | 114 | 0.110 |
Why?
|
| Gene Expression | 6 | 2008 | 7582 | 0.110 |
Why?
|
| Phosphates | 2 | 1996 | 763 | 0.100 |
Why?
|
| Leukemia, Experimental | 9 | 1991 | 224 | 0.100 |
Why?
|
| Carya | 1 | 2012 | 2 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 425 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 5 | 2001 | 508 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 701 | 0.100 |
Why?
|
| Monocytes | 5 | 2014 | 2591 | 0.100 |
Why?
|
| Multigene Family | 2 | 2000 | 1081 | 0.100 |
Why?
|
| Trichuriasis | 1 | 2012 | 24 | 0.100 |
Why?
|
| Flow Cytometry | 12 | 2008 | 5881 | 0.100 |
Why?
|
| Cricetinae | 7 | 1999 | 2413 | 0.100 |
Why?
|
| Langerhans Cells | 4 | 1994 | 169 | 0.100 |
Why?
|
| DNA | 9 | 1996 | 7193 | 0.100 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2017 | 122 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1996 | 812 | 0.100 |
Why?
|
| Transcription, Genetic | 8 | 2001 | 7600 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1159 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 683 | 0.090 |
Why?
|
| Interleukin-2 | 3 | 2006 | 1894 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2000 | 121 | 0.090 |
Why?
|
| Killer Cells, Natural | 6 | 1997 | 2206 | 0.090 |
Why?
|
| Autoimmunity | 2 | 2016 | 1354 | 0.090 |
Why?
|
| Ubiquitins | 1 | 1993 | 365 | 0.090 |
Why?
|
| Cell Communication | 2 | 2000 | 1660 | 0.090 |
Why?
|
| Chromosome Mapping | 3 | 1990 | 4617 | 0.090 |
Why?
|
| Phospholipase C gamma | 4 | 1999 | 130 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 780 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2271 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 4 | 2000 | 225 | 0.090 |
Why?
|
| Malaria, Cerebral | 1 | 2011 | 136 | 0.090 |
Why?
|
| Immunoprecipitation | 3 | 2013 | 874 | 0.090 |
Why?
|
| Eosinophils | 5 | 2011 | 946 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1993 | 792 | 0.080 |
Why?
|
| Swine | 4 | 2012 | 5986 | 0.080 |
Why?
|
| Histamine Release | 3 | 1999 | 117 | 0.080 |
Why?
|
| Neutrophils | 3 | 2012 | 3771 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1993 | 1056 | 0.080 |
Why?
|
| Chimera | 2 | 1996 | 455 | 0.080 |
Why?
|
| Protein Binding | 11 | 2014 | 9301 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 10 | 2016 | 22341 | 0.080 |
Why?
|
| Sodium | 3 | 2004 | 1591 | 0.080 |
Why?
|
| Mastocytoma | 1 | 2008 | 5 | 0.080 |
Why?
|
| Bone Marrow Cells | 6 | 2012 | 2411 | 0.080 |
Why?
|
| Thymus Gland | 2 | 2009 | 1259 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 2003 | 340 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2000 | 640 | 0.080 |
Why?
|
| Antibodies | 3 | 1997 | 2415 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1996 | 1724 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 1995 | 283 | 0.080 |
Why?
|
| Disulfides | 1 | 1990 | 461 | 0.080 |
Why?
|
| Vaccinia virus | 4 | 2003 | 328 | 0.080 |
Why?
|
| Haptens | 3 | 1997 | 163 | 0.080 |
Why?
|
| Blotting, Western | 6 | 2013 | 5020 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1765 | 0.080 |
Why?
|
| Interleukin-13 | 2 | 2001 | 388 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2003 | 2877 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2010 | 940 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 2005 | 1205 | 0.070 |
Why?
|
| Dog Diseases | 1 | 2008 | 142 | 0.070 |
Why?
|
| CHO Cells | 5 | 1999 | 1373 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2000 | 91 | 0.070 |
Why?
|
| Cell Line, Transformed | 3 | 1998 | 858 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1967 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 2815 | 0.070 |
Why?
|
| Inflammation | 1 | 2007 | 10860 | 0.070 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2009 | 320 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 1997 | 1346 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3801 | 0.070 |
Why?
|
| RNA Interference | 2 | 2006 | 2828 | 0.070 |
Why?
|
| Phosphopeptides | 3 | 1997 | 240 | 0.070 |
Why?
|
| Lipid Bilayers | 1 | 1989 | 376 | 0.070 |
Why?
|
| Cats | 2 | 2005 | 972 | 0.070 |
Why?
|
| Genetic Linkage | 2 | 1989 | 2342 | 0.070 |
Why?
|
| Extracellular Space | 1 | 2008 | 563 | 0.070 |
Why?
|
| Ion Channels | 2 | 2001 | 1044 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 651 | 0.070 |
Why?
|
| Mastocytosis | 1 | 2008 | 150 | 0.060 |
Why?
|
| Plasmapheresis | 3 | 1986 | 205 | 0.060 |
Why?
|
| Thiadiazoles | 1 | 2006 | 64 | 0.060 |
Why?
|
| Mitochondria | 1 | 2019 | 3672 | 0.060 |
Why?
|
| Hypotension | 2 | 1982 | 885 | 0.060 |
Why?
|
| Vitronectin | 1 | 2005 | 40 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1990 | 1305 | 0.060 |
Why?
|
| Mice, Transgenic | 7 | 2014 | 9540 | 0.060 |
Why?
|
| Phytohemagglutinins | 1 | 2004 | 164 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1103 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2006 | 380 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2005 | 115 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 723 | 0.060 |
Why?
|
| Proteins | 2 | 1996 | 5995 | 0.060 |
Why?
|
| Clone Cells | 1 | 2008 | 1671 | 0.060 |
Why?
|
| Cytosol | 3 | 2003 | 885 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 9 | 2005 | 9237 | 0.060 |
Why?
|
| Inositol Phosphates | 3 | 1999 | 174 | 0.060 |
Why?
|
| Phosphatidylinositols | 3 | 1994 | 276 | 0.050 |
Why?
|
| Exons | 3 | 2016 | 2393 | 0.050 |
Why?
|
| Cycloheximide | 2 | 2001 | 339 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 1118 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2011 | 1716 | 0.050 |
Why?
|
| Phospholipids | 3 | 1986 | 776 | 0.050 |
Why?
|
| Immunoglobulin M | 2 | 2000 | 1527 | 0.050 |
Why?
|
| Hemoperfusion | 1 | 1983 | 13 | 0.050 |
Why?
|
| Social Behavior | 1 | 2010 | 1143 | 0.050 |
Why?
|
| Tunicamycin | 2 | 1995 | 108 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4408 | 0.050 |
Why?
|
| Adenocarcinoma | 3 | 1986 | 6363 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2003 | 156 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2007 | 1966 | 0.050 |
Why?
|
| Anilides | 1 | 2006 | 413 | 0.050 |
Why?
|
| Membrane Microdomains | 2 | 2003 | 203 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 114 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5784 | 0.050 |
Why?
|
| Immune Complex Diseases | 1 | 1982 | 50 | 0.050 |
Why?
|
| Antibody Affinity | 2 | 1996 | 251 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 8038 | 0.050 |
Why?
|
| Models, Biological | 6 | 2003 | 9445 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2003 | 373 | 0.050 |
Why?
|
| Capsaicin | 1 | 2003 | 230 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2003 | 423 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 1982 | 1791 | 0.050 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2001 | 70 | 0.050 |
Why?
|
| Anti-Allergic Agents | 1 | 2003 | 153 | 0.050 |
Why?
|
| Enzyme Inhibitors | 4 | 2008 | 3722 | 0.050 |
Why?
|
| RNA, Messenger | 8 | 2005 | 12775 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 187 | 0.050 |
Why?
|
| Solubility | 4 | 1998 | 1077 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2005 | 894 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 4565 | 0.050 |
Why?
|
| Leucine | 3 | 2000 | 547 | 0.050 |
Why?
|
| Fibronectins | 1 | 2005 | 721 | 0.050 |
Why?
|
| Cell Movement | 2 | 2014 | 5196 | 0.050 |
Why?
|
| Fear | 1 | 2010 | 1496 | 0.050 |
Why?
|
| Peptide Mapping | 3 | 1997 | 259 | 0.050 |
Why?
|
| Protein Kinases | 2 | 2001 | 1611 | 0.050 |
Why?
|
| Asthma | 2 | 2014 | 6268 | 0.040 |
Why?
|
| Isoleucine | 1 | 2000 | 111 | 0.040 |
Why?
|
| Sphingosine | 2 | 2008 | 306 | 0.040 |
Why?
|
| Drug Design | 2 | 2003 | 1040 | 0.040 |
Why?
|
| Learning | 1 | 2010 | 1755 | 0.040 |
Why?
|
| Immunoglobulin Fragments | 1 | 2000 | 83 | 0.040 |
Why?
|
| Mutation | 9 | 2008 | 30209 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2007 | 883 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1107 | 0.040 |
Why?
|
| Carbachol | 2 | 2003 | 223 | 0.040 |
Why?
|
| Sequence Alignment | 4 | 2006 | 2174 | 0.040 |
Why?
|
| Exocytosis | 2 | 2006 | 323 | 0.040 |
Why?
|
| Hematopoiesis | 2 | 2001 | 2060 | 0.040 |
Why?
|
| Detergents | 5 | 1986 | 235 | 0.040 |
Why?
|
| Mice, Inbred NZB | 2 | 1989 | 57 | 0.040 |
Why?
|
| Mice, Inbred AKR | 2 | 1989 | 103 | 0.040 |
Why?
|
| Schistosomiasis mansoni | 2 | 1997 | 94 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2001 | 425 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 1994 | 1751 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2006 | 1181 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2001 | 428 | 0.040 |
Why?
|
| Biopolymers | 1 | 2000 | 181 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 2 | 1989 | 283 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 899 | 0.040 |
Why?
|
| Valine | 1 | 2000 | 410 | 0.040 |
Why?
|
| Cell Differentiation | 6 | 2008 | 11642 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2000 | 240 | 0.040 |
Why?
|
| Tetanus Toxoid | 1 | 1999 | 186 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 18321 | 0.040 |
Why?
|
| Blood Platelets | 2 | 2001 | 2464 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 1999 | 1149 | 0.040 |
Why?
|
| Sepsis | 1 | 2012 | 2603 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3089 | 0.040 |
Why?
|
| Mice, Inbred DBA | 2 | 1989 | 624 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3692 | 0.040 |
Why?
|
| Potassium | 1 | 2002 | 1312 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 2743 | 0.040 |
Why?
|
| Dogs | 3 | 2008 | 3824 | 0.040 |
Why?
|
| Dinitrobenzenes | 1 | 1997 | 37 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1997 | 43 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2017 | 48 | 0.040 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1996 | 43 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 931 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2001 | 1133 | 0.030 |
Why?
|
| Glycine | 1 | 2000 | 671 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 1997 | 1748 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2000 | 992 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3424 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2013 | 12130 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1996 | 199 | 0.030 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 101 | 0.030 |
Why?
|
| Ovalbumin | 2 | 2014 | 674 | 0.030 |
Why?
|
| Parasites | 1 | 1999 | 159 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 853 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 524 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 1996 | 333 | 0.030 |
Why?
|
| Genistein | 1 | 1996 | 87 | 0.030 |
Why?
|
| Glycosylation | 2 | 1998 | 1099 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2000 | 711 | 0.030 |
Why?
|
| HLA-C Antigens | 1 | 1996 | 146 | 0.030 |
Why?
|
| Extracorporeal Circulation | 2 | 1986 | 182 | 0.030 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 1996 | 198 | 0.030 |
Why?
|
| Cross-Linking Reagents | 2 | 2014 | 687 | 0.030 |
Why?
|
| Isoflavones | 1 | 1996 | 139 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2008 | 10433 | 0.030 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1995 | 93 | 0.030 |
Why?
|
| Interleukin-3 | 2 | 1997 | 423 | 0.030 |
Why?
|
| Trachea | 1 | 2001 | 1094 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1677 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1995 | 197 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2001 | 1518 | 0.030 |
Why?
|
| Cell Migration Assays | 1 | 2014 | 22 | 0.030 |
Why?
|
| Micelles | 2 | 1985 | 190 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 5090 | 0.030 |
Why?
|
| Papain | 1 | 2014 | 66 | 0.030 |
Why?
|
| Binding Sites | 4 | 2001 | 6001 | 0.030 |
Why?
|
| Hemodynamics | 2 | 1982 | 4188 | 0.030 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1996 | 249 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2008 | 102 | 0.030 |
Why?
|
| Skin | 4 | 1997 | 4482 | 0.030 |
Why?
|
| Dermatitis, Atopic | 3 | 1997 | 724 | 0.030 |
Why?
|
| Peptides | 2 | 1997 | 4338 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2001 | 2003 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 203 | 0.030 |
Why?
|
| Chronic Disease | 3 | 1998 | 9354 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2013 | 1546 | 0.030 |
Why?
|
| Phycoerythrin | 1 | 1993 | 9 | 0.030 |
Why?
|
| Body Temperature | 1 | 1997 | 781 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1995 | 429 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1886 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 1986 | 21074 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 17071 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1996 | 561 | 0.030 |
Why?
|
| Chemical Precipitation | 2 | 1991 | 173 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 1997 | 557 | 0.030 |
Why?
|
| Binding, Competitive | 4 | 1996 | 1140 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1992 | 113 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1992 | 100 | 0.030 |
Why?
|
| Histamine | 2 | 1992 | 495 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2001 | 647 | 0.030 |
Why?
|
| Schistosoma mansoni | 1 | 1994 | 154 | 0.030 |
Why?
|
| DNA Probes | 2 | 1990 | 541 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 1999 | 1490 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 189 | 0.030 |
Why?
|
| Arsenicals | 1 | 1992 | 117 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1994 | 573 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 2455 | 0.020 |
Why?
|
| Methionine | 2 | 1992 | 569 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 480 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1996 | 3405 | 0.020 |
Why?
|
| Th2 Cells | 1 | 1997 | 1074 | 0.020 |
Why?
|
| Thermodynamics | 2 | 2001 | 577 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 772 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1994 | 353 | 0.020 |
Why?
|
| Ligands | 3 | 2008 | 3274 | 0.020 |
Why?
|
| Insulin | 1 | 2006 | 6604 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 368 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1996 | 1498 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
| Ultrafiltration | 2 | 1982 | 46 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2003 | 3400 | 0.020 |
Why?
|
| Crystallography, X-Ray | 3 | 2001 | 1947 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 902 | 0.020 |
Why?
|
| Endosomes | 1 | 2014 | 521 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 4780 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 663 | 0.020 |
Why?
|
| Perfusion | 2 | 1986 | 1408 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 498 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1983 | 2532 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1998 | 443 | 0.020 |
Why?
|
| Plasmodium berghei | 1 | 2011 | 161 | 0.020 |
Why?
|
| Biological Transport | 1 | 1995 | 2080 | 0.020 |
Why?
|
| Female | 13 | 2016 | 396233 | 0.020 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2010 | 40 | 0.020 |
Why?
|
| Primates | 1 | 1993 | 519 | 0.020 |
Why?
|
| Peritonitis | 1 | 2012 | 368 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3684 | 0.020 |
Why?
|
| Genomic Library | 1 | 1990 | 189 | 0.020 |
Why?
|
| Feedback | 1 | 1994 | 796 | 0.020 |
Why?
|
| Kidney | 2 | 2002 | 7072 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1982 | 2504 | 0.020 |
Why?
|
| Endocytosis | 1 | 2014 | 952 | 0.020 |
Why?
|
| Species Specificity | 2 | 1996 | 2406 | 0.020 |
Why?
|
| Hybridomas | 1 | 1990 | 442 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 1982 | 578 | 0.020 |
Why?
|
| DNA Primers | 1 | 1993 | 2824 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 1989 | 29 | 0.020 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 1989 | 16 | 0.020 |
Why?
|
| Crystallization | 2 | 2001 | 518 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2008 | 63 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 1989 | 297 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 932 | 0.020 |
Why?
|
| Spectrin | 1 | 1988 | 174 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 893 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 1939 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 258 | 0.020 |
Why?
|
| Cell Survival | 2 | 2012 | 5747 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1998 | 3227 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2001 | 840 | 0.020 |
Why?
|
| Granulocytes | 1 | 1989 | 548 | 0.020 |
Why?
|
| Cysteine | 1 | 1992 | 898 | 0.020 |
Why?
|
| Biological Factors | 1 | 1989 | 155 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1998 | 4162 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 1988 | 752 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 1066 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2010 | 368 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1996 | 1897 | 0.020 |
Why?
|
| Liver | 2 | 1997 | 7559 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1993 | 6059 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2213 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1993 | 3073 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4910 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4263 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 487 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 415 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1993 | 3623 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1986 | 307 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13635 | 0.020 |
Why?
|
| Polyethylene Glycols | 3 | 1986 | 1189 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 860 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2000 | 6612 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1989 | 1616 | 0.020 |
Why?
|
| Iodine Radioisotopes | 2 | 1985 | 1029 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1989 | 1525 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1991 | 1075 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1983 | 5454 | 0.010 |
Why?
|
| Recurrence | 1 | 1997 | 8494 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2005 | 812 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1993 | 2864 | 0.010 |
Why?
|
| Peritoneal Cavity | 2 | 1997 | 135 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5126 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1984 | 189 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 575 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1536 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1989 | 1739 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1990 | 1801 | 0.010 |
Why?
|
| Male | 12 | 2010 | 363935 | 0.010 |
Why?
|
| Plasma Exchange | 1 | 1984 | 160 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2003 | 89 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1994 | 316 | 0.010 |
Why?
|
| Benzamides | 1 | 2008 | 1376 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2001 | 4210 | 0.010 |
Why?
|
| Binding Sites, Antibody | 2 | 1997 | 340 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 2005 | 2091 | 0.010 |
Why?
|
| Alleles | 1 | 1993 | 6892 | 0.010 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2001 | 13 | 0.010 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 1 | 2001 | 23 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1982 | 116 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2003 | 242 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1981 | 82 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2001 | 398 | 0.010 |
Why?
|
| Uremia | 1 | 1982 | 202 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1528 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1656 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 2001 | 143 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2001 | 261 | 0.010 |
Why?
|
| Immunophenotyping | 2 | 1996 | 1865 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2001 | 243 | 0.010 |
Why?
|
| Ascites | 1 | 1982 | 336 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1664 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2001 | 345 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2010 | 3576 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2001 | 472 | 0.010 |
Why?
|
| Rabbits | 1 | 1985 | 4730 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1999 | 74 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1994 | 2469 | 0.010 |
Why?
|
| Nociceptors | 1 | 2003 | 460 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 842 | 0.010 |
Why?
|
| Oncogene Protein v-akt | 1 | 1999 | 130 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1999 | 340 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 8113 | 0.010 |
Why?
|
| Time Factors | 4 | 1996 | 40108 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1211 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 1061 | 0.010 |
Why?
|
| Blood | 1 | 1981 | 597 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1993 | 5791 | 0.010 |
Why?
|
| Mesothelioma | 1 | 1984 | 774 | 0.010 |
Why?
|
| Strongyloides | 1 | 1997 | 3 | 0.010 |
Why?
|
| Nippostrongylus | 1 | 1997 | 21 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 1984 | 706 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 3338 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2590 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1467 | 0.010 |
Why?
|
| Strongylida Infections | 1 | 1997 | 48 | 0.010 |
Why?
|
| Leukocytes | 2 | 1997 | 2030 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 825 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 1996 | 56 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 1998 | 192 | 0.010 |
Why?
|
| Tryptophan | 1 | 1998 | 483 | 0.010 |
Why?
|
| Pyridines | 1 | 2008 | 2889 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1998 | 173 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 881 | 0.010 |
Why?
|
| Interleukins | 1 | 2001 | 789 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 1996 | 120 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1996 | 194 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1996 | 146 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1982 | 8532 | 0.010 |
Why?
|
| Octoxynol | 2 | 1986 | 76 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 3801 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 313 | 0.010 |
Why?
|
| Leukemia | 1 | 1983 | 1522 | 0.010 |
Why?
|
| Eosinophil Peroxidase | 1 | 1994 | 22 | 0.010 |
Why?
|
| Peptide Hydrolases | 2 | 1990 | 608 | 0.010 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 1995 | 101 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1376 | 0.010 |
Why?
|
| Peroxidases | 1 | 1994 | 134 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1996 | 608 | 0.010 |
Why?
|
| Glucose | 1 | 2006 | 4335 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12426 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1995 | 490 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1996 | 616 | 0.010 |
Why?
|
| Platelet Activation | 1 | 1997 | 643 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1996 | 444 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1996 | 880 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5758 | 0.010 |
Why?
|
| RNA | 2 | 1996 | 2716 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 9521 | 0.010 |
Why?
|
| Galectin 3 | 1 | 1995 | 238 | 0.010 |
Why?
|
| Transgenes | 1 | 1996 | 1014 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6208 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 900 | 0.010 |
Why?
|
| Immunization | 1 | 1997 | 1218 | 0.010 |
Why?
|
| Filtration | 2 | 1984 | 227 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1997 | 54812 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1494 | 0.010 |
Why?
|
| Phagocytes | 1 | 1994 | 292 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 1213 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1999 | 1365 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1206 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1992 | 219 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1982 | 1961 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13616 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1996 | 959 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 1695 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 1674 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1996 | 1362 | 0.010 |
Why?
|
| Adult | 5 | 1997 | 223139 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 3637 | 0.010 |
Why?
|
| Microinjections | 1 | 1990 | 319 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1990 | 556 | 0.010 |
Why?
|
| Echocardiography | 1 | 1982 | 5041 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1996 | 1852 | 0.010 |
Why?
|
| Eosinophilia | 1 | 1994 | 553 | 0.000 |
Why?
|
| Autoradiography | 1 | 1990 | 723 | 0.000 |
Why?
|
| Leukemia, Mast-Cell | 1 | 1988 | 13 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1990 | 695 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4909 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 4112 | 0.000 |
Why?
|
| Karyotyping | 1 | 1990 | 1175 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1997 | 1516 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1997 | 2916 | 0.000 |
Why?
|
| Xenopus laevis | 1 | 1990 | 965 | 0.000 |
Why?
|
| Skin Diseases | 1 | 1994 | 1083 | 0.000 |
Why?
|
| Brain | 1 | 2013 | 27177 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 3606 | 0.000 |
Why?
|
| Mortality | 1 | 1997 | 2911 | 0.000 |
Why?
|
| Oocytes | 1 | 1990 | 1168 | 0.000 |
Why?
|
| Heart Rate | 1 | 1997 | 4204 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2267 | 0.000 |
Why?
|
| Middle Aged | 3 | 1986 | 223083 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1986 | 404 | 0.000 |
Why?
|
| Chemistry | 1 | 1984 | 325 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 483 | 0.000 |
Why?
|
| Cell Division | 1 | 1992 | 4466 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1992 | 1928 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1984 | 521 | 0.000 |
Why?
|
| Azides | 1 | 1983 | 120 | 0.000 |
Why?
|
| Glucosamine | 1 | 1983 | 128 | 0.000 |
Why?
|
| Methyltransferases | 1 | 1986 | 373 | 0.000 |
Why?
|
| Plasma Volume | 1 | 1982 | 31 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1986 | 853 | 0.000 |
Why?
|
| Plasma Substitutes | 1 | 1982 | 56 | 0.000 |
Why?
|
| Venous Pressure | 1 | 1982 | 55 | 0.000 |
Why?
|
| Membranes | 1 | 1982 | 164 | 0.000 |
Why?
|
| Renal Veins | 1 | 1982 | 103 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1984 | 2543 | 0.000 |
Why?
|
| Amino Acids | 1 | 1987 | 1710 | 0.000 |
Why?
|
| Liposomes | 1 | 1984 | 786 | 0.000 |
Why?
|
| Suction | 1 | 1982 | 268 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 26381 | 0.000 |
Why?
|
| Temperature | 1 | 1984 | 2227 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1986 | 1893 | 0.000 |
Why?
|
| Aged | 2 | 1986 | 171219 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1986 | 4746 | 0.000 |
Why?
|